0000000000691488

AUTHOR

Annette Hasenburg

showing 46 related works from this author

Feasibility of an induced metabolic bioluminescence imaging technique in ovarian cancer: Results of a pilot study.

2016

e17093Background: The precise determination of energy metabolites is challenged by the heterogeneity of their distribution, their rapid changes after surgical resection and the architectural comple...

Surgical resectionCancer Researchmedicine.medical_specialtybusiness.industrymedicine.diseaseOncologymedicineBioluminescence imagingDistribution (pharmacology)sense organsRadiologyskin and connective tissue diseasesOvarian cancerbusinessJournal of Clinical Oncology
researchProduct

Patient Reported Outcome in metastatic breast cancer and platinum-resistant recurrent ovarian cancer treated with metronomic cyclophosphamide ± metho…

2021

Oncologymedicine.medical_specialtybusiness.industrymedicine.diseaseMetastatic breast cancerRecurrent Ovarian CancerInternal medicineMedicinePatient-reported outcomeMethotrexatebusinessMetronomic cyclophosphamidePlatinum resistantmedicine.drugSenologie - Zeitschrift für Mammadiagnostik und -therapie
researchProduct

Prognostic Significance of Focal Adhesion Kinase in Node-Negative Breast Cancer.

2017

<b><i>Background:</i></b> Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that plays an important role as a mediator of cell migration, invasion, proliferation and survival. Conflicting results for the prognostic role of FAK in breast cancer (BC) prompted us to determine its impact. <b><i>Methods:</i></b> Patients with node-negative BC entered this retrospective study. FAK expression was determined by immunohistochemistry (n = 335). The prognostic impact of FAK was examined with Cox regression analyses and Kaplan-Meier estimation in the whole cohort as well as in different molecular subtypes. <b><i>Results:</i>&l…

0301 basic medicineOncologymedicine.medical_specialtyUnivariate analysisProportional hazards modelbusiness.industryHazard ratioRetrospective cohort studymedicine.diseaseConfidence intervalFocal adhesion03 medical and health sciences030104 developmental biology0302 clinical medicineBreast cancerOncology030220 oncology & carcinogenesisInternal medicinemedicineImmunohistochemistrySurgeryOriginal ArticlebusinessBreast care (Basel, Switzerland)
researchProduct

Immunohistochemical analysis of IGCK expression in early breast cancer patients treated with adjuvant chemotherapy

2020

Oncologymedicine.medical_specialtyAdjuvant chemotherapybusiness.industryInternal medicinemedicineImmunohistochemistrybusinessEarly breast cancerGeburtshilfe und Frauenheilkunde
researchProduct

253 PFS of elderly ovarian cancer patients might be predicted by G-8 geriatric screening tool – results of a retrospective cohort study

2021

Introduction/Background* The aim of this study was to evaluate the impact of the preoperative global health status on the prognosis of patients with ovarian cancer (OC) older than 60 years, who received cytoreductive surgery. Methodology G-8 geriatric screening tool (G-8 score), Lee Schonberg prognostic index, Eastern Cooperative Oncology Group (ECOG) performance status and Charlson Comorbidity Index (CCI) were determined retrospectively in a consecutive cohort of elderly patients with OC. Univariate and multivariate Cox regression analyses and Kaplan-Meier method were performed to analyze the impact of the preoperative global health status on survival. Result(s)* 116 patients entered the s…

Multivariate statisticsmedicine.medical_specialtyMultivariate analysisPerformance statusbusiness.industryProportional hazards modelUnivariateRetrospective cohort studymedicine.diseaseInternal medicineCohortmedicineOvarian cancerbusinessOvarian cancer
researchProduct

EP1168 The influence of obesity on tumor recurrence in vulvar cancer patients

2019

Introduction/Background Obesity is associated with decrased survival in several cancer entities. The influence of obesity on prognosis of vulvar cancer patients is not clear. However, knowledge about this may have consequences on treatment and follow-up. Methodology This is an analysis of the large AGO-CaRE-1 study which included vulvar cancer patients (UICC stage IB and higher), treated in 29 cancer centers between 1998 and 2008, in order to analyze treatment patterns and prognostic factors. Results In total, 849 eligible patients were divided into two groups depending on their body mass index (BMI, 0.05). Radical vulvectomies were performed more frequently in patients having a BMI ≥30 kg/…

medicine.medical_specialtybusiness.industryCancerSubgroup analysisVulvar cancermedicine.diseaseObesityTumor recurrenceTime to recurrenceInternal medicineMedicineIn patientbusinessBody mass indexePoster
researchProduct

786 Fertility-sparing and minimally invasive surgery in patients with stage I malignant ovarian germ cell tumours in Germany

2021

Introduction/Background* Malignant ovarian germ cell tumours (OGCT) often affect women of younger age at an early stage of disease who may desire fertility conservation. The Arbeitsgemeinschaft fuer Gynaekologische Onkologie (AGO) has established a clinicopathological (Current Ovarian geRm cell and SEx cord stromal Tumour Treatment strategies, CORSETT) database to describe treatment strategies and outcomes for these women. Methodology 20 German centres entered mixed retro- and prospective data of 56 FIGO stage I OGCT patients treated between 2000 to 2014 into the CORSETT database. An independent CORSETT pathology reference panel re-evaluated the primary histological diagnosis. A descriptive…

Gynecologymedicine.medical_specialtyPregnancyendocrine system diseasesmedicine.diagnostic_testbusiness.industrymedicine.diseasemedicine.anatomical_structuremedicineDysgerminomaIn patientCystTeratomaStage (cooking)LaparoscopybusinessGerm cellFertility pregnancy
researchProduct

KDM5B and CBX5 as potential tumor-associated immunogenic antigens in triple-negative breast cancer (TNBC)

2021

Antigenbusiness.industryCancer researchMedicinebusinessTriple-negative breast cancerSenologie - Zeitschrift für Mammadiagnostik und -therapie
researchProduct

345 Comparison of cisplatin and mitomycin/5-FU as radiosensitizers in the treatment of vulvar cancer – results of a single institutional cohort study

2021

Introduction/Background* Treatment of vulvar cancer contains surgery if applicable and often primary or neo-/adjuvant chemoradiation. Cisplatin and Mitomycin/5-FU are widely used radiosensitizers in vulvar cancer, although evidence is limited. We retrospectively investigated both radiosensitizers for outcome and toxicity. Methodology We screened the archive for patients treated with chemoradiation for pathologically-confirmed squamous cell cancer of the vulva between 01/2010 – 02/2021 at our institution. The impact of both radiosensitizers on prognosis was compared using Kaplan-Meier method and Cox-Regression analysis. Result(s)* 127 patients with vulvar cancer were screened. 24 patients re…

Cisplatinmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentVulvar cancermedicine.diseaseGastroenterologyVulvamedicine.anatomical_structureInternal medicineToxicityMedicineStage (cooking)businessAdverse effectAdjuvantmedicine.drugCohort studyVaginal and vulvar cancer
researchProduct

Fertility After Ovarian Cystectomy: How Does Surgery Affect IVF/ICSI Outcomes?

2019

Abstract Introduction For patients considering undergoing assisted reproductive techniques (ART), many concerns arise when persistent ovarian cysts are found. This large study aimed to determine how ovarian cyst removal affects success rates of IVF/ICSI therapies. Methods 550 patients who underwent an IVF/ICSI treatment between 2002 and 2011 with a persistent ovarian cyst ≤ 5 cm before treatment were analyzed retrospectively. 328 patientsʼ preference was to undergo a laparoscopic cystectomy and 222 patients opted for a conservative management. Control subjects included 13 552 patients undergoing IVF/ICSI at the same period of time without an ovarian cyst. Results After adjusting for age, pa…

medicine.medical_specialtyfertilization ratemedia_common.quotation_subjectFertilityovarian cystMaternity and MidwiferymedicineGebFra Scienceklinische SchwangerschaftsrateOvarialzysteOozytenzahlmedia_commonBefruchtungsrateLaparoscopic cystectomyOvarian cystbusiness.industryIVF/ICSIObstetrics and GynecologyIvf icsioocyte numberControl subjectsmedicine.diseaseclinical pregnancy ratesSurgeryPregnancy rateOriginal ArticleOvarian cystectomyLive birthbusinessGeburtshilfe und Frauenheilkunde
researchProduct

237 Selected global health assessment tools significantly predict postoperative clinical outcome in elderly patients with ovarian cancer

2021

Introduction/Background* This study evaluated the impact of the global health status on the rate of postoperative clinical complications in patients with ovarian cancer (OC) older than 60 years. Methodology Selected global health status assessment tools were retrospectively determined in a cohort of OC patients older than 60 years, treated at our institution between 2008 and 2019. The primary outcome was the incidence and type of postoperative clinical complications in accordance with the Veteran Affairs’ National Surgical Quality Improvement Program (NSQIP). Differences in binary and ordinal variables between independent groups were analyzed by the chi-square test. Furthermore, rank correl…

medicine.medical_specialtybusiness.industryIncidence (epidemiology)medicine.diseaseAcs nsqipStatus assessmentPrimary outcomeInternal medicineCohortmedicineGlobal healthIn patientOvarian cancerbusinessOvarian cancer
researchProduct

Pain experience and social support of endometriosis patients during the COVID-19 pandemic in Germany – results of a web-based cross-sectional survey

2021

Background Endometriosis is a chronic pain condition in premenopausal women. Pain is mainly characterized by pain intensity and may induce disability in all areas of daily life. Nevertheless, pain is influenced by emotional and social factors as well. Social distancing measures or quarantine, as reaction to rapidly rising infections with the COVID-19 virus due to the SARS-CoV-2 pandemic, were implemented across Europe to prevent the spread of the virus and social distancing measures were imposed by the German government by beginning of March 2020 with initiation of the lockdown by the end of March 2020. The objective of this study was to assess, how social distancing measures during the lo…

Viral DiseasesCross-sectional studyEpidemiologyEmotionsEndometriosisSocial SciencesSocial DistancingDisability EvaluationMedical ConditionsGermanySurveys and QuestionnairesMedicine and Health SciencesMedicinePsychologySocial isolationPain MeasurementQuarantinesMultidisciplinarySocial distanceQRChronic painPain PerceptionInfectious DiseasesSocial IsolationQuarantineMedicineFemalemedicine.symptomChronic PainResearch ArticleAdultmedicine.medical_specialtyInfectious Disease ControlVisual analogue scaleScienceLower Back PainEndometriosisPainSocial supportSigns and SymptomsPain ManagementHumansPandemicsRetrospective StudiesInternetbusiness.industrySARS-CoV-2Biology and Life SciencesCOVID-19Social SupportRetrospective cohort studyCovid 19medicine.diseaseCross-Sectional StudiesPhysical therapyClinical MedicinebusinessPLoS ONE
researchProduct

Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes

2020

Interferons are crucial for adaptive immunity and play an important role in the immune landscape of breast cancer. Using microarray-based gene expression analysis, we examined the subtype-specific prognostic significance of interferon-&gamma

OncologyMicroarrayReceptor ErbB-2animal diseasesKaplan-Meier Estimatelcsh:ChemistryMedicinelcsh:QH301-705.5Spectroscopymolecular subtypesHazard ratioGeneral MedicineinterferonMiddle AgedAcquired immune systemProgression-Free SurvivalComputer Science ApplicationsGene Expression Regulation NeoplasticReceptors EstrogenCohortFemaleReceptors ProgesteroneSignal Transductionmedicine.medical_specialtyBreast Neoplasmschemical and pharmacologic phenomenaDisease-Free SurvivalArticleCatalysisInorganic ChemistryInterferon-gammaBreast cancerImmune systembreast cancerInternal medicineBiomarkers TumorHumansPhysical and Theoretical ChemistryMolecular BiologyAgedNeoplasm Stagingbusiness.industryProportional hazards modelOrganic Chemistrybreast cancer ; prognosis ; interferon ; molecular subtypesbiochemical phenomena metabolism and nutritionGene signaturemedicine.diseaselcsh:Biology (General)lcsh:QD1-999bacteriaprognosisbusinessInternational Journal of Molecular Sciences
researchProduct

The impact of intercellular communication for the generation of complex multicellular prevascularized tissue equivalents

2019

In reconstructive surgery the use of prevascularized soft tissue equivalents is a promising approach for wound coverage of defects after tumor resection or trauma. However, in previous studies to generate soft tissue equivalents on collagen membranes, microcapillaries were restricted to superficial areas. In this study, to understand which factors were involved in the formation of these microcapillaries, the levels of the angiogenic factors vascular endothelial growth factor (VEGF), Interleukin-8 (IL-8), and basic fibroblast growth factor (bFGF) in the supernatants of the tissue equivalents were examined at various time points and conditions. Additionally, the influence of these factors on …

Vascular Endothelial Growth Factor AMaterials science0206 medical engineeringBasic fibroblast growth factor610 MedizinBiomedical EngineeringNeovascularization PhysiologicCell Communication02 engineering and technologyBiomaterialschemistry.chemical_compoundEquivalent610 Medical sciencesmedicineHumansFibroblastCells CulturedTube formationTissue EngineeringMicrocirculationInterleukin-8Metals and AlloysEndothelial CellsSoft tissueFibroblasts021001 nanoscience & nanotechnology020601 biomedical engineeringCoculture TechniquesCell biologyVascular endothelial growth factorEndothelial stem cellmedicine.anatomical_structurechemistryCeramics and CompositesFibroblast Growth Factor 20210 nano-technologyIntracellularJournal of Biomedical Materials Research Part A
researchProduct

A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refract…

2018

ABSTRACT We assessed the tolerability and antitumor activity of solitomab, a bispecific T-cell engager (BiTE®) antibody construct targeting epithelial cell adhesion molecule (EpCAM). Patients with relapsed/refractory solid tumors not amenable to standard therapy received solitomab as continuous IV infusion in a phase 1 dose-escalation study with six different dosing schedules. The primary endpoint was frequency and severity of adverse events (AEs). Secondary endpoints included pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity. Sixty-five patients received solitomab at doses between 1 and 96 µg/day for ≥28 days. Fifteen patients had dose-limiting toxicities (DLTs): e…

lcsh:Immunologic diseases. Allergy0301 basic medicinemedicine.medical_specialtyImmunologyAMG 110bispecificlcsh:RC254-282Gastroenterology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSolitomabRefractoryPharmacokineticsInternal medicineImmunology and AllergyMedicineAdverse effectOriginal Researchbusiness.industryEpCAM phase 1Epithelial cell adhesion moleculesolitomablcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensBiTE®CD3Discontinuation030104 developmental biologyMT110OncologyTolerabilitychemistry030220 oncology & carcinogenesisPharmacodynamicssolid tumorimmunotherapylcsh:RC581-607businessOncoimmunology
researchProduct

Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population

2021

Women with cervical cancer, especially those with advanced disease, appear to experience suffering that is more prevalent, complex, and severe than that caused by other cancers and serious illnesses, and approximately 85% live in low- and middle-income countries where palliative care is rarely accessible. To respond to the highly prevalent and extreme suffering in this vulnerable population, we convened a group of experienced experts in all aspects of care for women with cervical cancer, and from countries of all income levels, to create an essential package of palliative care for cervical cancer (EPPCCC). The EPPCCC consists of a set of interventions, medicines, simple equipment, social s…

Cervical cancerGynecologic CancerCancer Researchmedicine.medical_specialtyPalliative carebusiness.industryPsychological interventionMEDLINEmedicine.diseaseSPECIAL ARTICLES03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisFamily medicineHealth caremedicineIncome levelVulnerable population030212 general & internal medicineHuman resourcesbusinessJCO Global Oncology
researchProduct

Management von Patientinnen mit gynäkologischem Sarkom – Eine Umfrage zur Behandlungspraxis der betreuenden GynäkologInnen im Rahmen der REGSA-Studie…

2018

Geburtshilfe und Frauenheilkunde
researchProduct

Cervical Cancer-Associated Suffering: Estimating the Palliative Care Needs of a Highly Vulnerable Population

2021

PURPOSE To enable design of optimum palliative care for women with cervical cancer, we studied the most common types of suffering and their severity, prevalence, and duration. METHODS We first reviewed the literature on the major types, severity, prevalence, and duration of suffering associated with cervical cancer. We then conducted a modified Delphi process with experts in cervical cancer care to supplement the literature. For each type of suffering, we distinguished between decedents (those who die from cervical cancer in a given year) and nondecedents (those who have cervical cancer in a given year but do not die). By applying the suffering prevalence and duration estimates to the numbe…

Cervical cancerGynecologic CancerCancer Researchmedicine.medical_specialtyPalliative carebusiness.industryMEDLINEORIGINAL REPORTSmedicine.disease03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesismedicineVulnerable population030212 general & internal medicineIntensive care medicinebusinessJCO Global Oncology
researchProduct

Metronomic Chemotherapy for Metastatic Breast Cancer.

2021

<b><i>Background:</i></b> As disease control and quality of life play a leading role in metastatic breast cancer (MBC), metronomic chemotherapy (MCT) is gaining popularity alongside conventional chemotherapy (CCT) and targeted therapies. <b><i>Summary:</i></b> MCT, defined as continuous administration of low-dose chemotherapeutic agents, is accepted as a therapy that exerts its effects via immunomodulation, anti-angiogenesis and direct cytotoxic effects. Oral administration of MCT is safe, easy to handle, and allows for flexible drug dosing. Dose accumulations associated with non-tolerable side effects are rare, so the medication can be admini…

OncologyCancer Researchmedicine.medical_specialtyCyclophosphamideReceptor ErbB-2Antineoplastic AgentsBreast NeoplasmsVinorelbinelaw.inventionCapecitabineRandomized controlled triallawOral administrationInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansCyclophosphamideCapecitabinebusiness.industryHematologymedicine.diseaseMetastatic breast cancerMetronomic ChemotherapyOncologyQuality of LifeMethotrexateFemalebusinessmedicine.drugOncology research and treatment
researchProduct

70 Patient reported outcome in platinum-resistant recurrent ovarian cancer and metastatic breast cancer treated with metronomic chemotherapy

2021

Introduction/Background* In the treatment of both platinum-resistant recurrent ovarian cancer (ROC) and metastatic breast cancer (MBC), symptom control and maintenance of quality of life (QoL) play a crucial role. In the advanced stage of disease, metronomic chemotherapy (MCT) may be a favourable treatment option. The aim of this study is to assess the QoL of heavily pretreated patients with ROC and MBC treated with MCT. Methodology PROmetronomic, FoR.UM 19-02193, is a monocentric, open-label, single-arm observational study to assess health-related patient-reported outcome data in ROC and MBC patients treated with MCT (cyclophosphamide 50 mg p.o. daily ± methotrexate 2.5 mg p.o. every other…

OncologyChemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCancerCommon Terminology Criteria for Adverse Eventsmedicine.diseaseMetronomic ChemotherapyMetastatic breast cancerTolerabilityQuality of lifeInternal medicinemedicinePatient-reported outcomebusinessOvarian cancer
researchProduct

Auswirkungen der sozialen Isolation bzw. der häuslichen Quarantäne während der SARS-CoV-2 Pandemie auf die Krankheitsbewältigung von Endometriose-Pat…

2020

Geburtshilfe und Frauenheilkunde
researchProduct

Cancer and Pregnancy: A Comprehensive Review

2021

Simple Summary The co-occurrence of cancer and pregnancy is fortunately a rare event. It is a challenging situation for all involved parties, as the risks and benefits of oncological treatments should be balanced for both the mother and the offspring. This work offers guidance to clinicians regarding the choice of diagnostic and therapeutic procedures, as well as regarding the management of the pregnancy. Abstract Cancer diagnosis and treatment in pregnant women is a challenging situation. A multidisciplinary network of specialists is required to guide both, the expecting mother and the unborn child through the diagnostic workup and the cytotoxic therapy, by balancing the respective risks a…

Cancer Researchmedicine.medical_specialtydiagnostic proceduresfetal outcomeReviewtherapeutic procedures03 medical and health sciences0302 clinical medicineUnborn childMultidisciplinary approachmedicinecancer030212 general & internal medicineRisks and benefitsStage (cooking)Intensive care medicineCytotoxic TherapyRC254-282PregnancyNeoplasms. Tumors. Oncology. Including cancer and carcinogensCancermedicine.diseaseOncology030220 oncology & carcinogenesisFetal outcomepregnancyCancers
researchProduct

246 Survival of elderly patients with endometrial cancer – predicted by preoperative G-8 geriatric screening tool

2021

Introduction/Background* We evaluated the prognostic impact of various global health assessment tools in accordance to conventional prognostic factors in patients with endometrial cancer (EC) older than 60 years. Methodology G-8 geriatric screening tool (G-8 geriatric score), Lee Schonberg prognostic index (Lee-Index), Charlson Comorbidity Index (CCI) and American Society of Anesthesiologists (ASA-PS) – Physical Status System were retrospectively determined in a consecutive cohort of elderly patients with EC. Univariate and multivariate Cox regression analyses and Kaplan-Meier method were performed to determine the impact of the global health assessment tools on progression free survival (P…

medicine.medical_specialtyMultivariate statisticsMultivariate analysisbusiness.industryProportional hazards modelEndometrial cancerUnivariatemedicine.diseaseInternal medicineCohortMedicineProgression-free survivalbusinessGrading (tumors)Endometrial cancer
researchProduct

P–298 High prevalence of depression and anxiety in patients with endometriosis during the SARS-CoV–2 pandemic in Germany

2021

Abstract Study question The aim was to assess the prevalence of self-reported symptoms of depression and anxiety and the moderating factors influencing mental symptoms during the COVID–19 pandemic. Summary answer Endometriosis patients were at risk of developing mental disorders during the pandemic. Associated risk factors were: reduction of the social network and the employment status. What is known already Endometriosis is a disease affecting up to 10% of women of fertile age. The leading symptoms are sub- or infertility and chronic pain. Additionally, the psychological impact on womeńs life is enormous. Women with endometriosis show higher rates of depression, anxiety and emotional distr…

medicine.medical_specialty2019-20 coronavirus outbreakHigh prevalencebusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)RehabilitationEndometriosisObstetrics and Gynecologymedicine.diseaseAcademicSubjects/MED00905Endometriosis Endometrium and Fallopian Tube and Benign Disorders of the Endometrium and Fallopian TubePoster ViewingReproductive MedicineInternal medicinePandemicMedicineAnxietyIn patientmedicine.symptombusinessDepression (differential diagnoses)Human Reproduction (Oxford, England)
researchProduct

A retrospective analysis of immunohistochemical determined IRF4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian ca…

2018

Oncologymedicine.medical_specialtybusiness.industrymedicine.diseaseInterferonInternal medicineCohortRetrospective analysisMedicineImmunohistochemistrybusinessOvarian cancerPlatelet factor 4IRF4medicine.drugGeburtshilfe und Frauenheilkunde
researchProduct

382 Molecular classification of endometrial carcinoma substantially changing risk-assessment: Results from a european multicentre initiative

2021

Introduction/Background* Endometrial carcinoma patient care was based on histopathologic examination for many years. However, conventional pathologic features are known to suffer from high inter-observer variability and may be irreproducible in many cases. TCGA-derived molecular classification was shown to provide clinically meaningful data and was recently introduced to ESGO/ESTRO/ESP endometrial carcinoma consensus guidelines. It was the aim of this study to quantify alterations in risk-assessment if molecular classification is added to conventional prognosticators. Methodology Consecutive primary endometrial carcinoma patients diagnosed in 2016 were identified in participating centres. O…

medicine.medical_specialtybusiness.industryGynecologic oncologyDiseasePrecision medicineLower riskmedicine.diseaseMSH6Internal medicineCarcinomaMedicineStage (cooking)businessRisk assessmentEndometrial cancer
researchProduct

(TA)MUC1 as a potential new target for breast cancer therapy

2020

Oncologymedicine.medical_specialtyBreast cancerbusiness.industryInternal medicineMedicinebusinessmedicine.diseaseMUC1Geburtshilfe und Frauenheilkunde
researchProduct

Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study

2020

ObjectiveObesity is associated with worse survival and an increased risk of relapse in several malignancies. The influence of obesity on vulvar cancer recurrence has not been previously described. The primary objective of this study was to evaluate the association between obesity and tumor recurrence in patients with vulvar cancer.MethodsThis is an analysis of the AGO-CaRE-1 study. Patients diagnosed with squamous cell vulvar cancer (stage IB and higher), treated in 29 cancer centers between January 1998 and December 2008, were registered in a centralized database. The cohort was divided into two gropus depending on the body mass index (BMI) (<30 vs ≥30 kg/m²). Descriptive statistics, su…

Adultmedicine.medical_specialtyBody Mass IndexYoung Adult03 medical and health sciences0302 clinical medicineQuality of lifeGermanyInternal medicinemedicineHumansObesityAgedNeoplasm StagingAged 80 and over030219 obstetrics & reproductive medicineVulvar Neoplasmsbusiness.industryObstetrics and GynecologyCancerMiddle AgedVulvar cancermedicine.diseaseObesityIncreased riskOncologyTime to recurrence030220 oncology & carcinogenesisCohortCarcinoma Squamous CellFemaleNeoplasm Recurrence LocalbusinessBody mass indexInternational Journal of Gynecologic Cancer
researchProduct

LION-PAW: Lymphadenectomy in ovarian neoplasm-pleasure ability of women—Prospective substudy of the randomized multicenter LION study.

2018

5575Background: There is limited information regarding the impact of radical surgery including pelvic and para-aortic lymphadenectomy (LNE) and subsequent chemotherapy on sexuality in patients (pts...

Cancer ResearchChemotherapymedicine.medical_specialty030219 obstetrics & reproductive medicinebusiness.industrymedicine.medical_treatmentmedia_common.quotation_subjectGeneral surgerymedicine.diseasePleasure03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesismedicineNeoplasmLymphadenectomyIn patientRadical surgerybusinessmedia_commonJournal of Clinical Oncology
researchProduct

Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst…

2017

524 Background: Hormone receptor positive breast cancer is a therapeutic challenge. Despite optimal anti-endocrine therapies, most breast cancer deaths follow a diagnosis of early luminal cancer. To understand the impact of multiple aberrations in the context of current therapy, we assessed the prognostic ability of genomic signatures as a putative stratification tool to targeted therapies. Methods: This a priori study is based on molecular pathways which might predict response to targeted therapies. DNA from 420 patients from the phase III TEAM pathology cohort were used. Patients with a distant recurrence within 5 years were matched by clinical variables to those disease-free at follow u…

Cancer Researchbusiness.industryCopy number analysisCancerContext (language use)Bioinformaticsmedicine.diseaseBreast cancerOncologyHormone receptorCohortmedicineCopy-number variationbusinessGeneJournal of Clinical Oncology
researchProduct

The Impact of Insulin on Low-dose Metronomic Vinorelbine and Mafosfamide in Breast Cancer Cells

2021

Background/aim Breast cancer (BC) may be affected by diabetes and anti-diabetic medication, as well as its therapeutic agents. Low-dose metronomic chemotherapy (LDMC) is an available treatment option in BC. We investigated the impact of insulin on low-dose metronomic vinorelbine and mafosfamide in BC cell lines. Materials and methods Human BC cell lines T-47D, MCF-7, MDA-MB-231, BT-549 and non-tumorigenic breast cell line MCF-10A were exposed to 0.01 μg/ml and 10 μg/ml insulin in combination with low-dose metronomic vinorelbine or mafosfamide. The cell viability was determined after 24-72 hours using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Results Insulin, especi…

Cancer ResearchCell Survivalmedicine.medical_treatmentAntineoplastic AgentsBreast NeoplasmsPharmacologyVinorelbinechemistry.chemical_compoundBreast cancerMafosfamideCell Line TumormedicineHumansInsulinCytotoxic T cellViability assayCyclophosphamidebusiness.industryInsulinVinorelbineGeneral Medicinemedicine.diseaseMetronomic ChemotherapyOncologychemistryAdministration MetronomicFemalebusinessmedicine.drugHormoneAnticancer Research
researchProduct

Rituximab-induziertes Pyoderma gangraenosum (PG) des unteren weiblichen Genitale – eine potentiell lebensbedrohliche Erkrankung

2020

Geburtshilfe und Frauenheilkunde
researchProduct

Prognostic Impact of Immunoglobulin Kappa C in Breast Cancer Patients Treated with Adjuvant Chemotherapy.

2020

<b><i>Introduction:</i></b> Immunoglobulin κC (IGKC)-positive tumor-infiltrating plasma cells are associated with better prognosis in node-negative breast cancer patients without adjuvant systemic therapy. In the present study we evaluated the prognostic significance of IGKC in breast cancer patients treated with adjuvant chemotherapy ± tamoxifen. <b><i>Methods:</i></b> IGKC expression was immunohistochemically analyzed in 193 breast cancer patients who were treated with adjuvant chemotherapy, either with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) or 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) between 1993 and 2001 wit…

Oncologymedicine.medical_specialtyChemotherapyCyclophosphamideProportional hazards modelbusiness.industrymedicine.medical_treatmentHazard ratiomedicine.diseaseLog-rank testBreast cancerOncologyInternal medicinemedicineSurgerybusinessTamoxifenEpirubicinmedicine.drugResearch ArticleBreast care (Basel, Switzerland)
researchProduct

317 Role of integrins in the metastatic spread of high-grade serous ovarian cancer

2021

Introduction/Background* In high-grade serous ovarian cancer (HGSOC) an early intraperitoneal metastatic spread is common which determines the therapeutical approach and prognosis. Integrins may be involved in metastatic spread of HGSOC. In this study, integrin expression was examined in primary tumour and metastases of HGSOC. Methodology The expression of integrin α2, α4, α5, α6, and β1 was assessed by immunostaining in tumour samples of the ovary, omentum, and peritoneum of each patient. Differences in integrin expression among tumour localisations and their association with clinicopathological parameters were examined by Fisher’s exact test. The impact of integrin expression on progressi…

Younger agebiologyProportional hazards modelbusiness.industryIntegrinOvaryExact testmedicine.anatomical_structurePeritoneumSerous ovarian cancermedicineCancer researchbiology.proteinbusinessImmunostainingOvarian cancer
researchProduct

Augmented Package of Palliative Care for Women With Cervical Cancer: Responding to Refractory Suffering

2021

The essential package of palliative care for cervical cancer (EPPCCC), described elsewhere, is designed to be safe and effective for preventing and relieving most suffering associated with cervical cancer and universally accessible. However, it appears that women with cervical cancer, more frequently than patients with other cancers, experience various types of suffering that are refractory to basic palliative care such as what can be provided with the EPPCCC. In particular, relief of refractory pain, vomiting because of bowel obstruction, bleeding, and psychosocial suffering may require additional expertise, medicines, or equipment. Therefore, we convened a group of experienced experts in…

Cervical cancerCancer Researchmedicine.medical_specialtyPalliative carebusiness.industrymedicine.medical_treatmentMEDLINEmedicine.diseaseBowel obstructionRadiation therapy03 medical and health sciences0302 clinical medicineOncologyRefractory030220 oncology & carcinogenesismedicineVomitingmedicine.symptomIntensive care medicinebusinessPsychosocial030217 neurology & neurosurgeryJCO Global Oncology
researchProduct

Full‐thickness tissue engineered oral mucosa for genitourinary reconstruction: A comparison of different collagen‐based biodegradable membranes

2020

Tissue engineering is a method of growing importance regarding clinical application in the genitourinary region. One of the key factors in successfully development of an artificially tissue engineered mucosa equivalent (TEOM) is the optimal choice of the scaffold. Collagen scaffolds are regarded as gold standard in dermal tissue reconstruction. Four distinct collagen scaffolds were evaluated for the ability to support the development of an organotypical tissue architecture. TEOMs were established by seeding cocultures of primary oral epithelial cells and fibroblasts on four distinct collagen membranes. Cell viability was assessed by MTT-assay. The 3D architecture and functionality of the ti…

Collagen Type IVScaffoldMaterials scienceSwineBiomedical EngineeringTenascinBiocompatible MaterialsMatrix (biology)Fibroblast migrationBiomaterials03 medical and health sciences0302 clinical medicineTissue engineeringAbsorbable ImplantsMaterials TestingmedicineAnimalsViability assayOral mucosaFibroblastCells CulturedTissue EngineeringTissue ScaffoldsbiologyKeratin-13Mouth MucosaEpithelial CellsMembranes ArtificialTenascin030206 dentistryFibroblastsPlastic Surgery ProceduresCoculture TechniquesUrogenital Surgical ProceduresCell biologymedicine.anatomical_structure030220 oncology & carcinogenesisbiology.proteinJournal of Biomedical Materials Research Part B: Applied Biomaterials
researchProduct

Primary Mucosal Epithelial Cell Cultivation: A Reliable and Accelerated Isolation

2019

We illustrate a reliable and accelerated isolation routine for mucosal epithelial cells, which thereupon can be used for soft tissue engineering. This is highly important in the field of soft tissue engineering because mucosal equivalents are frequently usable in several surgical fields like gynecology, urology, otorhinolaryngology, ophthalmology, maxillofacial surgery, and many others. In this context the isolation of mucosal epithelial cells suitable for tissue engineering is mandatory. The reliable cultivation of mucosal or skin epithelial cells is challenging and there is currently no reproducible method. We demonstrate a solution for this problem by developing an accelerated and nevert…

0303 health sciencesPrimary (chemistry)Tissue EngineeringIsolation (health care)0206 medical engineeringMouth MucosaBiomedical EngineeringMedicine (miscellaneous)Epithelial CellsBioengineeringCell Separation02 engineering and technologyBiology020601 biomedical engineeringEpitheliumCell biology03 medical and health sciencesmedicine.anatomical_structureCell cultureSoft tissue engineeringmedicineHumansCells Cultured030304 developmental biologyTissue Engineering Part C: Methods
researchProduct

Identification and analysis of tumor-associated antigens in triple-negative breast cancer (TNBC)

2020

business.industryCancer researchMedicineIdentification (biology)businessTumor associated antigenTriple-negative breast cancerGeburtshilfe und Frauenheilkunde
researchProduct

Monströser Uterus myomatosus in der 15. Schwangerschaftswoche

2020

Geburtshilfe und Frauenheilkunde
researchProduct

Targeted sequencing in a phase III trial of luminal breast cancer: Identification of novel targets.

2017

505 Background: The International Cancer Genome Consortium and The Cancer Genome Atlas have had a global transformative impact on our understanding of cancer. These programs have mapped the genomic landscape of common and rare tumors setting the scene for a comprehensive change in the approach to cancer diagnosis and treatment. However, the task remains incomplete until these mutational events are linked to clinical outcomes in the context of current therapeutic intervention to drive future stratified medicine approaches. Methods: We performed targeted sequencing in patients from the Tamoxifen Exemestane Adjuvant Multicentre trial. DNA was extracted and a 101 gene panel analysed using a no…

Cancer ResearchBreast cancerOncologybusiness.industryCancer genomemedicineComputational biologyBioinformaticsmedicine.diseasebusinessJournal of Clinical Oncology
researchProduct

A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduce…

2017

Only a fraction of breast cancer (BC) cases can be yet explained by mutations in genes or genomic variants discovered in linkage, genome-wide association and sequencing studies. The known genes entailing medium or high risk for BC are strongly enriched for a function in DNA double strand repair. Thus, aiming at identifying low frequency variants conferring an intermediate risk, we here investigated 17 variants (MAF: 0.01-0.1) in 10 candidate genes involved in DNA repair or cell cycle control. In an exploration cohort of 437 cases and 1189 controls, we show the variant rs3810813 in the SLX4/FANCP gene to be significantly associated with both BC (≤60 years; OR = 2.6(1.6-3.9), p = 1.6E-05) and…

0301 basic medicineGeneticsCancer ResearchCandidate geneHaplotypeLocus (genetics)Single-nucleotide polymorphismBiologyPenetrance03 medical and health sciences030104 developmental biologyOncologyAlleleAllele frequencyImputation (genetics)International Journal of Cancer
researchProduct

Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting

2019

We aimed to provide comprehensive protocols and promote effective management of pregnant women with gynecological cancers. New insights and more experience have been gained since the previous guidelines were published in 2014. Members of the International Network on Cancer, Infertility and Pregnancy (INCIP), in collaboration with other international experts, reviewed existing literature on their respective areas of expertise. Summaries were subsequently merged into a manuscript that served as a basis for discussion during the consensus meeting. Treatment of gynecological cancers during pregnancy is attainable if management is achieved by collaboration of a multidisciplinary team of health c…

0301 basic medicinemedicine.medical_specialtyCognitiveGenital Neoplasms FemaleInternational Cooperation[SDV.CAN]Life Sciences [q-bio]/CancerCancer Chemotherapy Cognitive Gynecologic Offspring Pregnancy[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics03 medical and health sciencesGenital Neoplasms Female/therapyGynecologicOffspring0302 clinical medicineSDG 3 - Good Health and Well-beingPregnancyHealth caremedicinePrenatal Exposure Delayed Effects/etiologyHumansChemotherapyRadiation treatment planningIntensive care medicineSocieties MedicalCancerPregnancy Complications Neoplastic/therapyPregnancyVaginal deliverybusiness.industryCancerHematologymedicine.diseasePrognosis3. Good healthCancer registryLong-term care030104 developmental biologyOncology030220 oncology & carcinogenesisPrenatal Exposure Delayed EffectsPractice Guidelines as TopicFemalePractice Guidelines as Topic/standardsbusinessBreast feedingPregnancy Complications Neoplastic
researchProduct

European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking sur…

2021

The European Society of Gynaecological Oncology (ESGO) developed and established for the first time in 2016, and updated in 2020, quality indicators for advanced ovarian cancer surgery to audit and improve clinical practice in Europe and beyond. As a sequela of the continuous effort to improve oncologic care in patients with ovarian cancer, ESGO issued in 2018 a consensus guidance jointly with the European Society of Medical Oncology addressing in a multidisciplinary fashion 20 selected key questions in the management of ovarian cancer, ranging from molecular pathology to palliation in primary and relapse disease. In order to complement the above achievements and consolidate the promoted sy…

medicine.medical_specialtyEvidence-based practicebusiness.industryObstetrics and GynecologyCancerGuidelines as TopicPerioperativeDiseaseAuditCarcinoma Ovarian Epithelialmedicine.diseaseDebulkingSurgeryScientific evidenceEuropeovarian cancerSettore MED/40 - GINECOLOGIA E OSTETRICIAOncologydebulking surgeryMedicineHumansFemalebusinessOvarian cancerPerioperative Period
researchProduct

Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.

2019

Lymph node ratio (LNR) can predict treatment outcome and prognosis in patients with solid tumors. Aim of the present analysis was to confirm the concept of using LNR for assessing outcome in patients with vulvar cancer after surgery with inguinal lymphadenectomy in a large multicenter project.The AGO-CaRE-1 study multicenter database was used for analysis. LNR was defined as ratio of number of positive lymph nodes (LN) to the number of resected. Previously established LNR risk groups were used to stratify patients. LNR was investigated with respect to clinical parameters. Univariate and multivariable survival analyses were performed to assess the value of LNR in order to predict overall (OS…

0301 basic medicineOncologyMalemedicine.medical_specialtyMedizinInguinal lymphadenectomyRisk AssessmentVulva03 medical and health sciences0302 clinical medicineRisk groupsPredictive Value of TestsInternal medicineNodal statusGermanymedicineHumansIn patientLymph nodeAgedNeoplasm StagingRetrospective StudiesVulvar Neoplasmsbusiness.industryObstetrics and GynecologyVulvar cancerMiddle Agedmedicine.diseasePrognosisSurvival Analysis030104 developmental biologymedicine.anatomical_structureOncology030220 oncology & carcinogenesisLymphatic MetastasisCarcinoma Squamous CellLymph Node ExcisionFemaleLymphLymph NodesbusinessGynecologic oncology
researchProduct

Riesen-Chorangiom der Plazenta – Ein Fallbericht

2018

Geburtshilfe und Frauenheilkunde
researchProduct

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

2021

SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in critically ill patients. Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri-operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism. We conducted a planned sub-study and analysis from an international, multicentre, prospective cohort study of elective and emergency patients undergoing surgery during October 2020. Patients from all surgical specialties were included. The primary outcome measure was venous thromboembolism (pulmonary embolism or deep vein thrombosis) within 30 da…

Malepulmonary embolismInternationalitySettore MED/18 - CHIRURGIA GENERALEDeep veinVascular damage Radboud Institute for Health Sciences [Radboudumc 16]infectious diseasesCardiovascularSARS‐CoV‐2surgeryCOVID-19 ; SARS-CoV-2 ; deep vein thrombosis ; pulmonary embolism ; venous thromboembolismCohort StudiesPostoperative ComplicationsAnesthesiologyMedicine and Health SciencesProspective Studies610 Medicine & healthProspective cohort studyLung11 Medical and Health SciencesConfoundingHematologyMiddle AgedThrombosis17 Psychology and Cognitive SciencesCOVID-19; deep vein thrombosis; pulmonary embolism; SARS-CoV-2; venous thromboembolismPulmonary embolismCOVID-19; SARS-CoV-2; deep vein thrombosis; pulmonary embolism; venous thromboembolism.medicine.anatomical_structureCohortCOVID-19/complicationsPostoperative Complications/etiologyOriginal ArticleFemalePatient SafetyLife Sciences & BiomedicineCOVID-19; SARS-CoV-2; deep vein thrombosis; pulmonary embolism; venous thromboembolismHumanAdultmedicine.medical_specialtyAdolescentClinical Sciencesvenous thromboembolism610 Medicine & healthGlobalSurg CollaborativeVenous Thromboembolism/etiologydeep vein thrombosisNOCOVIDSurg CollaborativeYoung AdultMedicine General & InternalAge DistributionClinical ResearchCOVID‐19General & Internal MedicinemedicineHumansSex DistributionAgedScience & Technologybusiness.industrySARS-CoV-2PreventionNeurosciencesdeep vein thrombosiCOVID-19PneumoniaOdds ratioOriginal Articlesmedicine.diseaseSurgeryReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Prospective StudieGood Health and Well BeingAnesthesiology and Pain MedicineHuman medicinePostoperative ComplicationCohort StudiebusinessVenous thromboembolism[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct